Comment on: Bringing Diagnostic Accuracy Back Into Focus: The Case of APRi in Biliary Atresia

jpedsurg.org

At the core of any diagnostic accuracy study lies the principle of discrimination—the ability of a biomarker or test to correctly classify individuals into clinically relevant groups. This is typically assessed through binary outcomes and metrics such as sensitivity, specificity, and likelihood ratios. Meta-analyses in this context must rely on appropriate diagnostic performance models, not on single-group pooled means across heterogeneous strata [1].

jpedsurg.org shows its articles on its own site.

Read the article on jpedsurg.org ↗

Article · Jun 2025 · 1 min read

In brief

This commentary addresses methodological concerns in diagnostic accuracy studies for biliary atresia, specifically the use of APRi as a biomarker. It emphasizes the importance of proper discrimination metrics and appropriate meta-analytic models rather than pooled means across heterogeneous patient groups.

Diagnostic accuracy studies fundamentally assess a test's ability to discriminate between clinically relevant patient groups.
Key metrics for evaluating diagnostic performance include sensitivity, specificity, and likelihood ratios.
Meta-analyses of diagnostic tests require appropriate performance models, not pooled means across heterogeneous populations.
Binary outcome classification is the standard framework for assessing biomarker diagnostic utility.

Written by the GCMD Library team from the article.

Read it at the source ↗